Abstract:Regulatory T (Treg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses1,2,3,4. Foxp3 operates as a late-acting differentiation factor controlling Treg cell homeostasis and function5, whereas the early Treg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors6,7,8,9,10. However, whether Foxo proteins act beyond the Treg-cell-commitment stage to control Treg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of Tregcell function. Treg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with Treg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of Treg cells. Genome-wide analysis of Foxo1 binding sites reveals ∼300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt–Foxo1 signalling module controls a novel genetic program indispensable for Treg cell function. The results of a series of genetic experiments indicate that Foxo1 has a pivotal, Foxp3-independent role controlling regulatory T-cell function. Foxo transcription factors are known to be involved in the control of immune homeostasis at least up to the regulatory T (Treg)-cell commitment stage. This paper reveals a crucial role for Foxo1 in the control of Treg-cell-dependent immune tolerance, independent of Foxo3. The authors propose that Treg cells co-opt the evolutionarily ancient Akt–Foxo1 signalling pathway to control a novel genetic program essential for Treg-cell function. This raises the possibility that manipulating the Akt–Foxo1 signalling pathway might offer a treatment for Treg-cell-associated immunological disorders.

Foxp3 depends on Ikaros for control of regulatory T cell gene expression and function

Foxp3 depends on Ikaros for control of regulatory T cell gene expression and function

Ikaros is a principal regulator of Aire + mTEC homeostasis, thymic mimetic cell diversity, and central tolerance

Identification and Characterization of Foxp3+ Γδ T Cells in Mouse and Human

IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function

Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

FOXP3 exon 2 controls T reg stability and autoimmunity

IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model

Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

The transcription factor Aiolos restrains the activation of intestinal intraepithelial lymphocytes

Lymphotoxin limits Foxp3+ regulatory T cell development from Foxp3lo precursors via IL-4 signaling

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

Ikaros antagonizes DNA binding by STAT5 in pre-B cells

The Transcription Factor ThPOK Regulates ILC3 Lineage Homeostasis and Function During Intestinal Infection.

Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells

IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development

Transcription Factors Foxo3a and Foxo1 Couple the E3 Ligase Cbl-b to the Induction of Foxp3 Expression in Induced Regulatory T Cells

T-regulatory cells require Sin3a for stable expression of Foxp3